Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.67 USD | +1.85% | -0.59% | 0.00% |
06-05 | ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment | MT |
06-05 | Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates | MT |
- Stock Market
- Equities
- AVBP Stock
- News ArriVent BioPharma, Inc.